当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Raghu Nandhan Sampath Kumar and Mohan Kameswaran
The quality of evidence presently available for assessing the Quality of life (QoL) outcomes in Cochlear implant (CI) users, is not of high level and is variable between cohorts and across centres of the world. There are many generic hearing-related quality of life measures available for assessment of the outcomes with the Glasgow benefit inventory (GBI) being the most popular, but these do not address in particular the diverse cultural, ethnic, cognitive, behavioural and socio-economic spectrum among the implantees. Since such confounders may influence the scoring system of these validated QoL tools, it is imperative to systematically analyze the existent literature to understand the quality of evidence available currently, how they may be upgraded or downgraded and to decipher the positives and negatives of the common GBI scoring system, to conclude upon the final level of evidence. Future directions for developing a systematic and universal guideline to asses QoL outcomes among cochlear implantees, can be inferred from such a critical appraisal.